MBIA Inc. (NYSE:MBI) tinted loss of -0.11% (-0.01 points) to US$9.37. The volume of 0.64 Million shares climbed down over an trading activity of 1.41 Million shares. EPS ratio determined by looking at last 12 month figures is -13.45. Over the same time span, the stock marked US$10.97 as its best level and the lowest price reached was US$6.04. The corporation has a market cap of US$806.48 Million.

MBIA Inc. (NYSE:MBI)’s earnings per share has been growing at a -32.8 percent rate over the past 5 year when average revenue increase was noted as -26 percent. The return on equity ratio or ROE stands at -103.3 percent while most common profitability ratio return on investment (ROI) was -19.3 percent. The company’s institutional ownership is monitored at 0 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 3 think it is Hold. Recently, analysts have updated the overall rating to 2.4. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Colgate-Palmolive Company (NYSE:CL) is worth US$57.05 Billion and has recently fallen -0.11% to US$65.17. The latest exchange of 2.5 Million shares is below its average trading activity of 4.6 Million shares. The day began at US$65.22 but the price moved to US$64.97 at one point during the trading and finally capitulating to a session high of US$65.63. The stock tapped a 52-week high of US$77.91 while the mean 12-month price target for the shares is US$70.6.

Currently, the stock carries a price to earnings ratio of 24.4, a price to book ratio of 0, and a price to sales ratio of 3.64. For the past 5 years, the company’s revenue has grown -2%, while the company’s earnings per share has grown 0.1%. With an institutional ownership near 75.9%, it carries an earnings per share ratio of 2.67.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 2 brokerage firms polled by Factset Research. At present, 14 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 1 analysts call it Underweight, while 3 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.7.